MedTrace Logo

Evaluation of the Prevalence of anomalIes of Glucose Metabolism in Patients Undergoing a Coronary Artery Bypass Graft (CABG)

NCT02855879 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 286

Last updated 2019-12-11

No results posted yet for this study

Summary

The aim of this study is to determine the prevalence of diabetes and non-diabetic glucose metabolism anomalies (glucose intolerance, non-diabetic fasting hyperglycaemia in patients about to undergo coronary artery bypass grafting (CABG).

In addition, the effect of these anomalies on post CABG morbi/mortality in the short term will be evaluated.

Conditions

  • Anomalies in Glucose Metabolism
  • Coronary Artery Bypass Graft

Interventions

OTHER

Collection of biological data

OTHER

Collection of clinical data

Sponsors & Collaborators

  • Centre Hospitalier Universitaire Dijon

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-08
Primary Completion
2019-06-05
Completion
2019-06-05

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02855879 on ClinicalTrials.gov